Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G for NEKTAR THERAPEUTICS Common Stock, $0.0001 par value (NKTR).
- Disclosed ownership: 7.4%.
- Date of event: 01 Jul 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 7.4% ownership in NEKTAR THERAPEUTICS Common Stock, $0.0001 par value (NKTR) on 01 Jul 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 3.8% | 661,758 | 0 | 661,758 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 3.8% | 661,758 | 0 | 661,758 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 3% | 517,813 | 0 | 517,813 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 3% | 517,813 | 0 | 517,813 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.4% | 71,367 | 0 | 71,367 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.4% | 71,367 | 0 | 71,367 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 6.8% | 1,179,571 | 0 | 1,179,571 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 7.4% | 1,276,595 | 0 | 1,276,595 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 7.4% | 1,276,595 | 0 | 1,276,595 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 7.4% | 1,276,595 | 0 | 1,276,595 | /s/ Mark N. Lampert | Mark N. Lampert |